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Abstract
Background: Complex interventions are widely used in health care, public health, education, criminology, social work, business, and
welfare. They have increasingly become the subject of systematic reviews and are challenging to effectively report. The Complex Interventions Methods Workgroup developed an extension to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses for
Complex Interventions (PRISMA-CI).
Rationale: Following the EQUATOR Network guidance for Preferred Reporting Items for Systematic Reviews and Meta-Analysis extensions, this Explanation and Elaboration (EE) document accompanies the PRISMA-CI checklist to promote consistency in reporting of
systematic reviews of complex interventions.
Discussions: The EE document explains the meaning and rationale for each unique PRISMA-CI checklist item and provides examples
to assist systematic review authors in operationalizing PRISMA-CI guidance. The Complex Interventions Workgroup developed PRISMACI as an important start toward increased consistency in reporting of systematic reviews of complex interventions. Because the field is
rapidly expanding, the Complex Interventions Methods Workgroup plans to re-evaluate periodically for the need to add increasing specificity and examples as the field matures. Ó 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BYNC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords: Complex interventions; Publishing standards; Research report standards; Health care interventions; Evidence-based medicine; Systematic review;
Research design; Review literature as topic; Guidance as topic

1. Introduction
Funding: This work was funded by the following contracts
HHSA290201200004C, HHSA290201200016I, and HHSA2902015000
11I from the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.
Conflicts of interest: The authors have no conflicts of interest to report.
The authors alone are responsible for the content and writing of the paper.
The authors of this report are responsible for its content. Statements in the
report should not be construed as endorsement by the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human
Services.
* Corresponding author. Tel.: þ1-503-494-2101; fax: þ1-503-4185074.
E-mail address: guisej@ohsu.edu (J.-M. Guise).

This is the final paper in the seven-part series of papers
presenting tools and approaches for Systematic Reviews for
Complex Interventions. This paper is intended to be a companion to the prior paper in the series [1] and describes examples and elaboration on how to apply the checklist for
Preferred Reporting Items for Systematic Reviews and
Meta-Analyses of Complex Interventions (PRISMA-CI).
Complex interventions in health care are challenging to
report effectively in a manner that supports intervention
replication. This reporting challenge in primary studies

http://dx.doi.org/10.1016/j.jclinepi.2017.06.017
0895-4356/Ó 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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permeates systematic reviews of complex interventions. In
addition to the difficulties of distilling information on individual studies that may be poorly reported, systematic reviews need to account for multiple sources of complexity
and selective reporting presented within and across
included studies. Five members of the Complex Interventions Steering Committee (J.-M.G., M.B., C.C., M.V., and
P.T.) established a consolidated definition of complex interventions (described in Guise et al. [2] and in Table 1) that
guided the development of a PRISMA-CI. The purpose of
this paper was to provide guidance and examples of how
to implement the PRISMA-CI checklist for systematic reviews of complex interventions.

complexity, in addition to traditional PRISMA items. In
addition, the review should report details according to
PRISMA-CI for the remaining dimensions of complexity
addressed by the review. This document provides a rationale and examples for the additional dimensions of
complexity. These are drawn from a limited set and are
not the only way to meet the PRISMA-CI goals.

2. Methods

To identify systematic reviews of complex intervention
topics, it is critical to indicate in the title that the review involves a complex intervention.

The PRISMA-CI statement itself provides details regarding
its background and development [1]. To briefly recap, to
develop PRISMA-CI extension guidance for reviews of complex interventions, we followed principles for the development
of health research reporting guidelines: identifying need, obtaining funding, reviewing the relevant literature, conducting
a broad survey, and exploring consensus [3,4]. International
multidisciplinary panels of experts in research, systematic reviews, and implementation of complex interventions participated in a multiphased process over a 3-year period to
develop guidance and tools for systematic reviewers to use
when conducting reviews of complex interventions. Five
members of the Complex Interventions Steering Committee
(J.-M.G., C.C., M.B., M.V., and P.T.) drafted specific items
for this document and discussed items regularly on conference
calls to further refine the document, which was circulated and
ultimately approved by the larger Complex Interventions
Workgroup and international leaders in systematic reviews
and in complex interventions.

3. PRISMA-CI: explanation and elaboration
This accompanying Explanation and Elaboration (EE)
document explains the meaning and rationale for additions
to PRISMA that are specific to complex interventions. Examples and elaboration are provided for each PRISMA-CI
checklist item [1] to clarify their use in reviews of complex
interventions. Original PRISMA items remain in the
PRISMA-CI checklist as they provide the traditional foundation for reporting elements of systematic reviews. The
reader should refer to prior published EE for standard
PRISMA items [5]. The PRISMA-CI extension provides
additional or revised reporting items that are specific to
the dimensions of complexity (see definition of complex
intervention, mentioned previously). There are many dimensions of complexity, and a given systematic review
may not intend to address all sources. All reviews of
complex interventions are expected to report their
specific objectives, pathway complexity, and intervention

3.1. PRISMA-CI additions/changes
3.1.1. Item 2, title
Specifically indicate that the focus of the systematic
review includes a complex intervention.

3.1.2. Item 4, objectives
Include in this statement the sources of (Table 1 definition of complex intervention) complexity of primary interest
A first step in the process of clarifying reporting standards for systematic reviews of complex interventions is
to clarify what constitutes complexity. Include in this statement which sources of complexity are of primary interest
(see definition of complex intervention, mentioned
previously).
3.1.2.1. Example. ‘‘The purpose of this report was to review the comparative clinical utility and diagnostic accuracy of risk assessment instruments for evaluating risk of
pressure ulcers and to evaluate the benefits and harms of
preventive interventions for pressure ulcers. People at risk
for pressure ulcers are cared for in diverse settings,
including acute care hospitals, long-term care facilities,
and the community at large. This report therefore also reviews how effectiveness varies in specific patient subgroups
and in different settings.’’ [6].
3.1.2.2. Elaboration. A critical step in reporting is to
clearly state and communicate the questions and important
elements of the scope of the review. Reviews of complex
interventions should explicitly include relevant complexity
elements. Individual systematic reviews may emphasize
one or more sources of complexity, such as population or
intervention delivery complexity, or may focus on elements
of complexity within a particular complexity source, such
as one treatment setting rather than another. The sources
of complexity that a review examines should arise in the
course of scope development. A review may be commissioned and scoped to inform specific decisions, including
clinical decision making, policy, coverage, identification
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Table 1. Definition of complex interventions [2]
All complex interventions have two common characteristics: they have
multiple components (intervention complexity) and they have
complicated/multiple causal pathways, feedback loops, synergies,
mediators, and moderators of effect (pathway complexity). In
addition, they may also have one or more of the following three
additional characteristics: target multiple participants, groups, or
organizational levels (population complexity); require multifaceted
adoption, uptake, or integration strategies (implementation
complexity); or work in a dynamic multidimensional environment
(contextual complexity).

of research gaps, or other purposes. Explicitly including the
information about the type of decision and the role of the
review provides insight into the timing, scoping, and focus
of the review, which in turn provide insight into why
certain areas of complexity were or were not included in
the scope.
3.2. Review methods
It is important for readers to know what information review authors sought, even if some of the information was
not available [7]. Reporting this level of detail informs
the reader about limitations in the knowledge base and also
informs potential avenues for future research. Consistency
in this level of reporting has been cited as a major
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limitation in the field of complex interventions. Audiences
of the review, including implementers and researchers,
report that this limitation creates inefficiencies when
searching for absent or inconsistent information and limits
their ability to use and apply review findings [8,9]. Items
11aef provide guidance, examples, and details for each
of the definitional components of complex interventions.
3.2.1. Item 11a, data items: pathway complexity
Include an analytic framework, causal pathway, or
other graphical representation of the chain of evidence to illustrate the complexity of the causal
pathway.
Because complex interventions can include many dimensions of complexity in topics, a graphical representation of the PICOTS relating to that topic and delineating
which are within the scope of the systematic review can
be very useful. It can help to specify which dimensions
are the primary focus of the review.
3.2.1.1. Example. Public reporting analytic framework illustrating contextual factors and varying population and organizational levels targeted by the complex intervention [10].
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3.2.1.2. Example. Behavior change analytic framework illustrating contextual factors, multiple approaches to intervention
component bundles, and both planned (Measures of Behavior
Change, Ongoing or Sustained Behavior Change) and
unplanned outcomes (Other Positive Outcomes, Adverse
Events) [11].

Quality (AHRQ) Evidence-based Practice Center
program, which has conventions to assist in its
communication and reproducibility [12e14]. Two
examples are provided for this AHRQ form; Anderson
and colleagues provide other approaches to logic
models [15].

3.2.1.3. Elaboration. Complex
interventionsdbecause
they can involve multiple components, multiple targets, multiple levels of a system, and number and variability in
planned and unplanned beneficial and harmful outcomesd
require special effort to assure the research questions, scope,
general analytic approach, and the pathway complexity are
adequately reported. An analytic framework provides a
graphical representation of the intervention, its target, the
scope of the review, and the relationships among variables.
We advise the authors to report analytic frameworks that link
the critical actions that lead from population identification to
desired outcomes (most commonly patient-important health
outcomes for clinical interventions) to clarify the focus and
guide the systematic review. The review research questions
should be visually integrated within the analytic framework,
and the PICOTS elements should be identifiable and map to
those listed in the body of the report.
No standard graphic will serve for all possible
review topics. Authors often create variations of a
form used by the Agency for Healthcare Research and

We realize that journals often limit the number of figures
and tables for a publication, and the PRISMA flowchart,
forest plots, or other results graphics compete for journal
space. Given the communication power of a visual depiction of the review questions, scope, and pathway
complexity, if insufficient space in the main article, we
encourage including the analytic framework in Web-based
supplemental materials if provided by the journal.
3.2.2. Item 11b, data items: intervention complexity
Include sufficient detail for the interventions’ components (including number, sequence, necessary vs.
discretionary, a priori vs. final), frequency, duration,
intensity, theoretical foundation, incentives, replicability, and people delivering the intervention.
3.2.2.1. Example. ‘‘This review examines the impact of
slum-upgrading programs on health and social well-being. A
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broad range of slum-upgrading approaches and their interlinkages with health and socioeconomic outcomes have been depicted in the logic model. These have been grouped into
proximal interventions within the living environment (physical
environment, social environment, service access, health promotion, and behavioral interventions) and distal strategies that
enable structures and systems to implement these proximal
environment interventions (policies, laws and regulations,
financial investment, community action, or a combination of
these factors). The logic model also demonstrates that strategies may be delivered by governments (global, national, state,
or local), the private sector, civil society, or by a combination
of these actors and stakeholders.’’ [16].
‘‘The number, breadth, and diversity of slum-upgrading
interventions outlined in the logic model are too broad to be
assessed in a single systematic review. This review, therefore, has focused on upgrading interventions involving
physical environment and infrastructure improvements,
with or without the integration of wider slum-upgrading approaches (e.g., policy, legal, financial, community action,
social, or service interventions). Where such studies deliver
multicomponent strategies, the nature of the full package of
interventions was examined.’’ [16].
3.2.2.2. Elaboration. Intervention complexity can arise
from many possible sources. Essential items to report
may include the following:






The number and description of all components
Necessary vs. optional or discretionary components
Intervention intensity
Intervention frequency
Replicability of interventiondprovide sufficient
detail so the intervention can be replicated
 Note the stated theoretical foundation for the intervention, that is, how the intervention is thought to work
 Intervention incentives
 A priori vs. final componentsddistinguishing which
were added or removed after the protocol was
established
Other optional items may include the following:
 The degree to which components are independent vs.
interactive/effect modifiers
 The theoretical basis for studies demonstrating replicability of the intervention
 Cost of intervention
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Include sufficient detail to describe who the intervention
targeted and the characteristics of the participants,
including skills or educational level required for and behaviors targeted by the intervention.
3.2.3.1. Example. ‘‘This review focuses on adults with
medical illness and complex care needs in the outpatient
setting. A main criterion in choosing studies for inclusion
was the existence of complex care needs. Complex care
needs were defined broadly, and we included studies with
case definitions based on health care resource utilization,
patient health outcomes, and/or multifactor assessments
that include measures such as socioeconomic status or patient self-efficacy . The population of interest included
all adults with medical illness and complex care needs.
To identify the broadest sample of literature relevant to
[case management] (CM) for such patients, we did not want
to limit the results of the literature search to any particular
disease condition or conditions. Our search was designed to
include all subpopulations with any medical illness and
complex care needs for whom CM had been studied. However, we excluded studies in which the primary clinical
problem was a psychiatric disorder (other than dementia)
and in which CM was used primarily to manage mental
illness or a substance abuse disorder.’’ [17].
3.2.3.2. Elaboration. The complexity contributed by the
populations can come in many forms. Complex interventions commonly require active participation from the study
participants more comprehensive than pharmacologic or
surgical interventions. Alternatively, the patients targeted
by the interventions may be more complicated medical
cases. Items that are generally essential to understand population complexity include the following:
 Who or what the intervention targets (e.g., individual,
population, health system, etc.).
 The skill and educational level required to participate
in the intervention.
 The medical and social risk status of the participants.
 The behaviors of the population that are targeted for
change.
 Participant demographics: age, gender, ethnicity,
language.
Other optional items might include other important cultural factors that characterize the population.
3.2.4. Item 11d, data items: implementation complexity

3.2.3. Item 11c, data items: population complexity
Include sufficient detail to describe who (or what system level) the intervention targeted and the characteristics of the participants (e.g., age, gender, ethnicity,
language, educational or skill level, medical & social
risk status, etc.).

Clearly define the adoption, uptake, or integration
strategies. Strategies can include facilitators (distinct
from intervention elements) such as including attestations, financial incentives, periodic reports of findings, reminders, supplemental trainings, or physical
environmental changes.
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3.2.4.1. Example. ‘‘Implementation strategies are methods
used by the practices to implement the changes needed to
be more consistent with the Patient-Centered Medical
Home (PCMH) [model of care], as well as the methods
used to measure the impact of the PCMH transformation
on clinical care processes or outcomes. The categories of
implementation strategies initially used for data abstraction
for this review include the following:
a.
b.
c.
d.
e.
f.
g.
h.
i.
j.
k.
l.

Audit and feedback to providers, teams, and/or clinics
Quality improvement measures
Academic detailing
Lectures/classes for staff (i.e., didactic education)
Designated clinical champion (facility/practice level)
Designated project manager (facility/practice level)
Plan-Do-Study-Act cycles/rapid cycle improvement
mechanisms
Flow mapping of care system
Total quality improvement/continuous quality
improvement
Strengths-weakness-opportunities-threats analysis
External benchmarking at the organizational level
Other

Through the data abstraction process, we found that we
often had to draw some inferences regarding the implementation strategy from the description of the process of change
to categorize them.’’ [18].
3.2.4.2. Elaboration. Complexity can arise in the short
term, when specific strategies may be required to establish
the intervention. These strategies are not required once the
intervention is established and therefore should be considered part of implementation complexity, rather than intervention complexity. Clearly define implementation
strategies or implementation facilitators such as including
attestations, financial incentives, periodic reports of findings, reminders, supplemental trainings, physical environmental changes. Distinguish these strategies or facilitators
from the intervention. Reporting on strategies or facilitators
of implementation complexity separately from intervention
complexity enables readers to understand techniques that
facilitate adoption of the intervention. Consistent reporting
across reviews on these factors allows crosscutting reports
on the effectiveness of implementation strategies overall.
3.2.5. Item 11e, data items: contextual complexity
Include details about the settings, locations where the
data were collected, or other contextual factors
(including financial, organizational, and clinical
setting). Provide rationale if not relevant.
3.2.5.1. Example. ‘‘The context of an intervention, for
example, the type of health care setting, the leadership

structure, the safety culture, the openness to innovation,
can have an important impact on whether preventive interventions are adopted. Furthermore, the ability to transfer a
successful quality improvement strategy from one setting to
another may depend in part on whether the contexts differ
[.these include:]
 Theory or logic model behind the patient safety
practice
 Structural organizational characteristics (such as size,
location, financial status, existing quality, and safety
infrastructure)
 External factors (such as regulatory requirements or
incentive systems)
 Patient safety culture, teamwork, and leadership at
the level of the unit
 Availability of implementation and management tools
(such as staff education and training, use of internal
audit and feedback, presence of internal or external
individuals responsible for implementation)
 Description of interveners, intervenees, and their
roles in the implementation process’’ [19].
3.2.5.2. Elaboration. Complex interventions typically
involve many actors and moving parts. As a result, contextual factors can influence complex interventions and should
be described in detail to clarify the wider ‘‘system’’ within
which the intervention is located. Intervention, implementation, and contextual complexity can be closely related
and need to be distinguished in the context of specific review. Review teams will need to rely on content experts,
extensive reading, or engagement with stakeholders (people
who will use, be affected by, or have an interest in the topic
of the evidence review) to ensure adequate subject-matter
expertise. An implementation factor for one complex intervention or one systematic review approach may be a
contextual factor for another. A guiding principle for distinguishing contextual complexity from intervention or implementation complexity is to consider whether geographic,
organizational, or other setting characteristics influence
the effectiveness of the intervention. These settings are
not an explicit component of the interventions or strategies
to implement interventions but may incidentally influence
outcomes. Frameworks, such as Consolidated Framework
for Implementation Research, comprehensively include
contextual factors that may be pertinent to complex interventions. Some essential items to report may include the
following:
 Organizational featuresdleadership at organizational
level
 Geographic location
 Financial setting (e.g., fee for service, capitation,
Medicare/Medicaid, uninsured)
 Clinical setting (e.g., solo or group private practice,
public health, integrated health plan)
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Optional items:
 Rival activities
3.2.6. Item 11f, data items: timing
Describe the absolute and relative timing of each of the
components of PICO. Specifically, describe the time at
which eligibility criteria (P) were set, the time at which
the interventions or treatment strategies (I, C) were assigned, and the time zero of follow-up when outcome
events started to be counted. Also describe the timing
of the components of interventions I and C during the
follow-up. Provide rationale if not relevant.
3.2.6.1. Example. ‘‘Data fields included author; year of
publication; setting, subject inclusion and exclusion
criteria; and study design characteristics. For KQ1, we also
abstracted intervention and control characteristics (intervention components, timing, frequency, duration); followup duration; participant baseline demographics; type of
CIS [clinically isolated syndrome] or MS [multiple sclerosis], MS severity; descriptions and results of outcomes
and adverse effects; reasons for discontinuation; and study
funding source.’’ [20].
3.2.6.2. Elaboration. The timing of intervention components and the relation to outcome ascertainment may be
important to note when it is related to other types of
complexity, such as pathway complexity and outcome
complexity. Provide sufficient timing detail so each of the
treatment strategies of interest could be replicated. At a
minimum, explain whether the treatment strategy consists
of a once-only intervention (e.g., surgery) or whether the
intervention is sustained over time (e.g., daily aspirin for
5 years). If the strategy is sustained over time, specify the
timing of the component interventions and whether it is a
static or dynamic strategy, that is, whether the intervention
changes over time. If the review will follow a formal analytic approach that treats the analysis as equivalent to an
observational study designed to mimic an ideal trialdthat
is, a trial optimally designed to address the research
questionddetail at the level of eligibility criteria (population), treatment strategies and possibly specific components, and follow-up for outcomes is critical. [21].
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need to continue to work on creative solutions to provide
transparency without sacrificing readability. New developments will enhance the portfolio of examples for systematic
reviews of complex interventions. We note the important role
of subject-matter and methods expertise, as exemplified by
the need for judgment in laying out objectives; depicting
pathway complexity; and distinguishing between intervention, implementation, and contextual complexity.
Researchers bear responsibility to their participants, funders, and the public for extracting as much meaning as
possible from their research. The PRISMA-CI tool can help
achieve this goal by taking advantage of changing trends in
scientific publishing. As journals shift reliance from paperbased to electronic dissemination, the use of supplements
and other enhanced electronic content such as ‘‘mouseover’’
or pop-up text and graphics can increase richness and detail
to the narrative. A clear articulation of reporting elements
necessary to build a cumulative body of evidence can
enhance efficiency in research without sacrificing readability.
We plan several activities to encourage broad dissemination and immediate implementation of PRISMA-CI: we
will write to PRISMA-endorsing journals and ask them to
consider endorsing PRISMA-CI, we will contact funding
agencies and professional organizations that commission
systematic reviews to consider recommending the use of
PRISMA-CI, and we will submit abstracts for major international conferences such as the Guidelines International
Network, Cochrane, and other professional meetings to
encourage PRISMA-CI use in the field.
We developed PRISMA-CI to establish a shared language
around the sources of complexity and to improve transparency and completeness of reporting. We followed processes
considered best practice in guideline development. [2] Our
development process has a number of strengths including
use of an independent process among a broad array of experts for item selection and prioritization (minimizing bias),
an in-person meeting promoting rich discussion, intensive
bimonthly expert calls for thoughtful consideration of items,
and broad international peer review of both the PRISMA-CI
checklist [1] and EE documents. Follow-on efforts are
planned to promote use and application. We expect that this
effort will improve transparency and accountability in reporting and better inform investments in the use of evidence
and research investments. Future revisions to this extension
may be needed as the field matures.

4. Conclusion
We present a limited number of examples and recognize
that reviewers may need to present shorter or more succinct
versions than those presented here. The examples used in this
document were by necessity drawn from a period before this
guidance. We offer these examples as a source of guidance
and inspiration to better describe systematic reviews of complex interventions. As more systematic reviews of complex
interventions are published, authors and journal editors will
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